Non-traditional CD4+CD25−CD69+ regulatory T cells are correlated to leukemia relapse after allogeneic hematopoietic stem cell transplantation
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1479-5876
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Non-traditional CD4+CD25−CD69+ regulatory T cells are correlated to leukemia relapse after allogeneic hematopoietic stem cell transplantation ; volume:12 ; number:1 ; day:1 ; month:7 ; year:2014 ; pages:1-10 ; date:12.2014
Journal of translational medicine ; 12, Heft 1 (1.7.2014), 1-10, 12.2014
- Creator
-
Zhao, Xiao-su
- Contributor
-
Wang, Xu-hua
Zhao, Xiang-yu
Chang, Ying-Jun
Xu, Lan-Ping
Zhang, Xiao-Hui
Huang, Xiao-Jun
SpringerLink (Online service)
- DOI
-
10.1186/1479-5876-12-187
- URN
-
urn:nbn:de:1111-2016041450764
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:50 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Zhao, Xiao-su
- Wang, Xu-hua
- Zhao, Xiang-yu
- Chang, Ying-Jun
- Xu, Lan-Ping
- Zhang, Xiao-Hui
- Huang, Xiao-Jun
- SpringerLink (Online service)
Other Objects (12)
Highly immunosuppressive myeloid cells correlate with early relapse after allogeneic stem cell transplantation
Blinatumomab for Acute Lymphoblastic Leukemia Relapse after Allogeneic Hematopoietic Stem Cell Transplantation
Genomic prediction of relapse in recipients of allogeneic haematopoietic stem cell transplantation
Intrathecal CAR-NK cells infusion for isolated CNS relapse after allogeneic stem cell transplantation: case report
The role of immune checkpoint molecules for relapse after allogeneic hematopoietic cell transplantation
Proteomics to predict relapse in patients with myelodysplastic neoplasms undergoing allogeneic hematopoietic cell transplantation
FLT3-inhibitor therapy for prevention and treatment of relapse after allogeneic hematopoietic cell transplantation
FLT3-inhibitor therapy for prevention and treatment of relapse after allogeneic hematopoietic cell transplantation
Combination of Donor Lymphocyte Infusion and Blinatumomab for B-Cell Lymphoblastic Lymphoma Relapse after Allogeneic Stem-Cell Transplantation
Correlation of nutrition-associated parameters with non-relapse mortality in allogeneic hematopoietic stem cell transplantation
Isolated central nervous system relapse of chronic myeloid leukemia after allogeneic hematopoietic stem cell transplantation
CMV prophylaxis with letermovir significantly improves graft and relapse free survival following allogeneic stem cell transplantation
Highly immunosuppressive myeloid cells correlate with early relapse after allogeneic stem cell transplantation
Blinatumomab for Acute Lymphoblastic Leukemia Relapse after Allogeneic Hematopoietic Stem Cell Transplantation
Genomic prediction of relapse in recipients of allogeneic haematopoietic stem cell transplantation
Intrathecal CAR-NK cells infusion for isolated CNS relapse after allogeneic stem cell transplantation: case report
The role of immune checkpoint molecules for relapse after allogeneic hematopoietic cell transplantation
Proteomics to predict relapse in patients with myelodysplastic neoplasms undergoing allogeneic hematopoietic cell transplantation
FLT3-inhibitor therapy for prevention and treatment of relapse after allogeneic hematopoietic cell transplantation
FLT3-inhibitor therapy for prevention and treatment of relapse after allogeneic hematopoietic cell transplantation
Combination of Donor Lymphocyte Infusion and Blinatumomab for B-Cell Lymphoblastic Lymphoma Relapse after Allogeneic Stem-Cell Transplantation
Correlation of nutrition-associated parameters with non-relapse mortality in allogeneic hematopoietic stem cell transplantation
Isolated central nervous system relapse of chronic myeloid leukemia after allogeneic hematopoietic stem cell transplantation
CMV prophylaxis with letermovir significantly improves graft and relapse free survival following allogeneic stem cell transplantation
Highly immunosuppressive myeloid cells correlate with early relapse after allogeneic stem cell transplantation
Blinatumomab for Acute Lymphoblastic Leukemia Relapse after Allogeneic Hematopoietic Stem Cell Transplantation
Genomic prediction of relapse in recipients of allogeneic haematopoietic stem cell transplantation
Intrathecal CAR-NK cells infusion for isolated CNS relapse after allogeneic stem cell transplantation: case report
The role of immune checkpoint molecules for relapse after allogeneic hematopoietic cell transplantation
Proteomics to predict relapse in patients with myelodysplastic neoplasms undergoing allogeneic hematopoietic cell transplantation
FLT3-inhibitor therapy for prevention and treatment of relapse after allogeneic hematopoietic cell transplantation
FLT3-inhibitor therapy for prevention and treatment of relapse after allogeneic hematopoietic cell transplantation
Combination of Donor Lymphocyte Infusion and Blinatumomab for B-Cell Lymphoblastic Lymphoma Relapse after Allogeneic Stem-Cell Transplantation
Correlation of nutrition-associated parameters with non-relapse mortality in allogeneic hematopoietic stem cell transplantation
Isolated central nervous system relapse of chronic myeloid leukemia after allogeneic hematopoietic stem cell transplantation